April 2026
The global enteric disease testing market size was evaluated at USD 4.30 billion in 2025 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
August 2025
The global mosquito-borne infections testing market size was estimated at USD 27.11 billion in 2024 and is expected to hit around USD 39.52 billion by 2034, growing at a CAGR of 3.84%.
July 2025
The biological safety testing market size was evaluated at USD 4.85 billion in 2024 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
July 2026
The global penetration testing market size was evaluated at USD 2.81 billion in 2025 and is predicted to hit around USD 8.51 billion by 2035, growing at a CAGR of 11.72%.
July 2026
The global endocrine testing market size was estimated at USD 15.63 billion in 2025 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%
July 2026
The global non-destructive testing equipment and services market size was evaluated at USD 9.03 billion in 2025 and is predicted to surge around USD 14.76 billion by 2035, growing at a CAGR of 5.03%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global EV battery testing market is growing as electric vehicle adoption drives demand for safety, performance, and durability testing.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The US direct-to-consumer laboratory testing market size was evaluated at USD 1.23 billion in 2025 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 9.03%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global pet DNA testing market size was valued at USD 447.94 million in 2025 and is expected to hit around USD 1,177.22 million by 2035, growing at a CAGR of 10.14% from 2026 to 2035.
June 2026
The global medical device testing market size is calculated at USD 10.76 billion in 2025 and is projected to hit around USD 25.82 billion by 2035 with a CAGR of 9.15%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global precision genomic testing market size is valued at USD 17.89 billion in 2025 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The global inhalation toxicology testing market size was evaluated at USD 432.06 million in 2025 and is predicted to hit around USD 1,062.62 million by 2035, growing at a CAGR of 9.45%.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global prenatal and newborn genetic testing market size is projected to hit around USD 30.94 billion by 2035, increasing from USD 9.28 billion in 2025, with at a solid CAGR of 12.8%.
June 2026
The non-destructive testing (NDT) market size accounted for USD 22.29 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
June 2026
The global rapid microbiology testing market size is expected to increase to USD 12.72 billion by 2035 from USD 6.75 billion in 2025 with a notable CAGR of 6.54%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global hemoglobin A1c testing devices market size is estimated to hit around USD 4.72 billion by 2035 from USD 2.52 billion in 2025, with a CAGR of 6.48%.
June 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 41.24 billion in 2025, with a CAGR of 5.55%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The global arbovirus testing market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com